Interaction between renin-angiotensin and sympathetic nervous systems in a rat model of pressure overload cardiac hypertrophy

Autonomic and Autacoid Pharmacology

Volumn 29, Issue 4, 2009, Pages 171-180

  Rathore, H A ^a   Munavvar, A S ^a   Abdullah, N A ^b   Khan, A H ^a   Fathihah, B ^a   Nurjannah, M H ^a   Raisa, N A ^a   Anand Swarup, K R L ^a   Abdullah, M H ^a   Salman, I M ^a   Johns, E J ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Alpha adrenoceptors; AT1 receptors; Interaction; Left ventricular hypertrophy; Renin angiotensin system; Sprague Dawley rats; Sympathetic nervous system

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; LOSARTAN; METHOXAMINE; NORADRENALIN; OXIDOPAMINE; PHENYLEPHRINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAPHY; EXPERIMENTAL MODEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANIMALS; AORTIC VALVE STENOSIS; BLOOD PRESSURE; CARDIOMEGALY; ELECTROCARDIOGRAPHY; MALE; METHOXAMINE; NOREPINEPHRINE; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 70349150190     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8665.2009.00445.x     Document Type: Article

References (40)

1. ABDULLA, M.H., SATTAR, M.A., SALMAN, I.M., ABDULLAH, N.A., AMEER, O.Z., KHAN MD, A.H. JOHNS, E.J. (2008). Effect of acute unilateral renal denervation on renal hemodynamics in spontaneously hypertensive rats. Auton. Autacoid. Pharmacol., 28, 87 94.
2. AKERS, W.S., CROSS, A., SPETH, R., DWOSKIN, L.P. CASSIS, L.A. (2000). Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol., 279, H2797 H2806.
3. 1A adrenoceptors in contraction of rat mesenteric artery. Vascul. Pharmacol., 40, 91 96.
4. ARMENIA, A., MUNAVVAR, A.S., ABDULLAH, N.A., HELMI, A. JOHNS, E.J. (2004). The contribution of adrenoceptor subtype(s) in the renal vasculature of diabetic spontaneously hypertensive rats. Br. J. Pharmacol., 142, 719 726.
5. BARON, R.D.W., ILSLEY, C., SHEIBAN, I., POOLE-WILSON, P.A. RICKARDS, A.F. (1980). R wave amplitude during exercise relation to left ventricular function and coronary artery disease. Am. J. Heart, 44, 512 517.
6. BAYORH, M.A., GANAFA, A.A., EATMAN, D., WALTON, M. FEUERSTEIN, G.Z. (2005). Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt induced hypertension. Am. J. Hypertens., 18, 1496 1502.
7. BAYORH, M.A., LAYAS, M.F., MANN, G., FEUERSTEIN, G.Z. EATMAN, D. (2007). The effect of diet on simvastatin and losartan enhancement of endothelial function. Clin. Exp. Hypertens., 29, 311 325.
8. 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens. Br. J. Pharmacol., 143, 745 752.
9. 1-adrenergic receptors in cardiomyopathic hamsters. J. Card. Fail., 6, 257 263.
10. DAVEY, P. (2004). The ECG in Clinical Decision Making. Royal Society of Medicine Press, London, 40 41.
11. DAVID, D., NAITO, M., CHEN, C.C., MICHELSON, E.L., MORGANROTH, J. SCHAFFENBURG, M. (1981). R-wave amplitude variations during acute experimental myocardial ischemia: an inadequate index for changes in intracardiac volume. Circulation, 63, 1364 1371.
12. GIORDANO, A., MELINA, G., CALCAGNI, M.L., SCHINZARI, F., CIRILLO, F., METTIMANO, M., CARDILLO, C. MELINA, D. (2007). Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy. Arch. Med. Res., 38, 512 518.
13. GREENWOOD, J.P., SCOTT, E.M., STOKER, J.B. MARY, D.A.S.G. (2001). Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive. J. Am. Coll. Cardiol., 38, 1711 1717.
14. GRIEVE, D.J. SHAH, A.M. (2003). Oxidative stress in heart failure - more than just damage. Eur. Heart J., 24, 2161 2163.
15. ILSLEY, C., CANEPA-ANSON, R., LANGLEY, G., FOALE, R., POOLE-WILSON, P. RICKARDS, A. (1981). R-wave amplitude and left ventricular volume: changes with nitroglycerine and atrial pacing. Am. J. Cardiol., 68 (Suppl. 2 153 160.
16. ISRAEL, A. SOSA-CANACHE, B. (2002). Angiotensin II supports sympathetically mediated vasopressor response to footshock-stress. J. Human Hyperten., 16, S84 S88.
17. KASAMA, S., TOYAMA, T., KUMAKURA, H., TAKAYAMA, Y., ICHIKAWA, S., SUZUKI, T. KURABAYASHI, M. (2003). Addition of valsartan to an angiotensin converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure. J. Nucl. Med., 44, 884 890.
18. LEVY, D., GARRISON, R.J., SAVAGE, D.D., KANNEL, W.B. CASTELLI, W.P. (1990). Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N. Engl. J. Med., 322, 1561 1566.
19. LI, Y.H., REDDY, A.K., OCHOA, L.N., PHAM, T.T., HARTLEY, C.J., MICHAEL, L.H., ENTMAN, M.L. TAFFET, G.E. (2003). Effect of age on peripheral vascular response to transverse aortic banding in mice. J. Gerontol. A Biol. Sci. Med. Sci., 58, B895 B899.
20. MCGOLDRICK, R.B., KINGSBURY, M., TURNER, M.A., SHERIDAN, D.J. HUGHES, A.D. (2007). Left ventricular hypertrophy induced by aortic banding impairs relaxation of isolated coronary arteries. Clin. Sci., 113, 473 478.
21. MORGAN, H.E. BAKER, K.M. (1991). Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation, 83, 13 25.
22. MUNTER, K., EHMKE, H. KIRCHENGAST, M. (1999). Maintenance of blood pressure in normotensive dogs by endothelin. Am. J. Physiol., 276, H1022 H1027.
23. PARADIS, P., DALI-YOUCEF, N., PARADIS, F.W., THIBAULT, G. NEMER, M. (2000). Overexpression of angiotensin II type 1 receptor in cardiomyocytes induces cardiac hypertrophy and remodelling. Proc. Natl. Acad. Sci. U.S.A., 97, 931 936.
24. PASSINO, C., FRANZON, F., GABUTTI, A., POLETTI, R., GALETTA, F. EMDIN, M. (2004). Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy. Int. J. Cardiol., 97, 57 62.
25. SADOSHIMA, J., XU, Y. SLAYTER, H.S. (1993). Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell, 75, 977 984.
26. SAWYER, D.B., SIWIK, D.A., XIAO, L., PIMENTEL, D.R., SINGH, K. COLUCCI, W.S. (2002). Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol., 34, 379 388.
27. SCHEUER, J. (1999). Catecholamines in cardiac hypertrophy. Am. J. Cardiol., 83, 70H 74H.
28. SCHMIEDER, R.E., HILGERS, K.F., SCHLAICH, M.P. SCHMIDT, B.M.W. (2007). Renin-angiotensin system and cardiovascular risk. Lancet, 369, 1208 1219.
29. 1 receptor blockade fails to attenuate pressure-overload cardiac hypertrophy in fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol., 273, 1501 1508.
30. SHELLI, L.K. PAULA, A.I. (2004). Autonomic nervous system pharmacogenomics: a progress report. Pharmacol. Rev., 56, 31 52.
31. STORY, D.F. ZIOGAS, J. (1987). Interaction of angiotensin II with noradrenergic transmission. Trends Pharmacol. Sci., 8, 269 271.
32. TEISMAN, A.C.H., WESTERINK, B.H.C., VAN VELDHUISEN, D.J., SCHOLTENS, E., DE ZEEUW, D. VAN GILST, W.H. (2000). Direct interaction between the sympathetic and renin-angiotensin system in myocardial tissue: a microdialysis study in anaesthetized rats. J. Auton. Nerv. Syst., 78, 117 121.
33. THALER, S.S. (1978). United States Patent 4091817. Available at http://www.freepatentsonline.com/4091817.html (accessed on 16 August 2009).
34. THOMAS, E.L. (2001). The sympathetic nervous system and long-term blood pressure regulation. Heart, 14, 147S 154S.
35. THOMAS, C.H., SHAWN, M.J., HIROKI, A., JEFFERY, D.M., ALLEN, W.C.J.R., SEIGO, I. BRUCE, E.M. (1997). Angiotensin II type 1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc. Natl. Acad. Sci., 94, 7543 7548.
36. ++ influx. J. Pharmacol. Exp. Ther., 36, 166 176.
37. TURCANI, M. RUPP, H. (1998). Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan. Mol. Cell. Biochem., 188, 225 233.
38. VAILE, J.C., FLETCHER, J., LITTLER, W.A., COOTE, J.H. TOWNEND, J.N. (1998). Angiotensin II modulates cardiovascular autonomic control in the absence of baroreflex loading. Heart, 80, 127 133.
39. WILLIAM, J.G. CINDY, L.S. (2001). Principles of Human Physiology, 2nd edn. Pearson Benjamin Cummings publisher Inc., NJ, USA.
40. YAMAZAKI, T., KOMURO, I. KUDOH, S. (1996). Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J. Biol. Chem., 271, 3221 3228. (Pubitemid 26055625)